TY - JOUR
T1 - Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection
AU - RV254/SEARCH010 RV304/SEARCH 013 Study Groups
AU - Muir, Roshell
AU - Metcalf, Talibah
AU - Tardif, Virginie
AU - Takata, Hiroshi
AU - Phanuphak, Nittaya
AU - Kroon, Eugene
AU - Colby, Donn J.
AU - Trichavaroj, Rapee
AU - Valcour, Victor
AU - Robb, Merlin L.
AU - Michael, Nelson L.
AU - Ananworanich, Jintanat
AU - Trautmann, Lydie
AU - Haddad, Elias K.
N1 - Publisher Copyright:
© 2016 Muir et al.
PY - 2016/7
Y1 - 2016/7
N2 - The RV254 cohort of HIV-infected very early acute (4thG stage 1 and 2) (stage 1/2) and late acute (4thG stage 3) (stage 3) individuals was used to study T helper- B cell responses in acute HIV infection and the impact of early antiretroviral treatment (ART) on T and B cell function. To investigate this, the function of circulating T follicular helper cells (cTfh) from this cohort was examined, and cTfh and memory B cell populations were phenotyped. Impaired cTfh cell function was observed in individuals treated in stage 3 when compared to stage 1/2. The cTfh/B cell cocultures showed lower B cell survival and IgG secretion at stage 3 compared to stage 1/2. This coincided with lower IL-10 and increased RANTES and TNF-α suggesting a role for inflammation in altering cTfh and B cell responses. Elevated plasma viral load in stage 3 was found to correlate with decreased cTfh-mediated B cell IgG production indicating a role for increased viremia in cTfh impairment and dysfunctional humoral response. Phenotypic perturbations were also evident in the mature B cell compartment, most notably a decrease in resting memory B cells in stage 3 compared to stage 1/2, coinciding with higher viremia. Our coculture assay also suggested that intrinsic memory B cell defects could contribute to the impaired response despite at a lower level. Overall, cTfh-mediated B cell responses are significantly altered in stage 3 compared to stage 1/2, coinciding with increased inflammation and a reduction in memory B cells. These data suggest that early ART for acutely HIV infected individuals could prevent immune dysregulation while preserving cTfh function and B cell memory.
AB - The RV254 cohort of HIV-infected very early acute (4thG stage 1 and 2) (stage 1/2) and late acute (4thG stage 3) (stage 3) individuals was used to study T helper- B cell responses in acute HIV infection and the impact of early antiretroviral treatment (ART) on T and B cell function. To investigate this, the function of circulating T follicular helper cells (cTfh) from this cohort was examined, and cTfh and memory B cell populations were phenotyped. Impaired cTfh cell function was observed in individuals treated in stage 3 when compared to stage 1/2. The cTfh/B cell cocultures showed lower B cell survival and IgG secretion at stage 3 compared to stage 1/2. This coincided with lower IL-10 and increased RANTES and TNF-α suggesting a role for inflammation in altering cTfh and B cell responses. Elevated plasma viral load in stage 3 was found to correlate with decreased cTfh-mediated B cell IgG production indicating a role for increased viremia in cTfh impairment and dysfunctional humoral response. Phenotypic perturbations were also evident in the mature B cell compartment, most notably a decrease in resting memory B cells in stage 3 compared to stage 1/2, coinciding with higher viremia. Our coculture assay also suggested that intrinsic memory B cell defects could contribute to the impaired response despite at a lower level. Overall, cTfh-mediated B cell responses are significantly altered in stage 3 compared to stage 1/2, coinciding with increased inflammation and a reduction in memory B cells. These data suggest that early ART for acutely HIV infected individuals could prevent immune dysregulation while preserving cTfh function and B cell memory.
UR - http://www.scopus.com/inward/record.url?scp=84982994525&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1005777
DO - 10.1371/journal.ppat.1005777
M3 - Article
C2 - 27463374
AN - SCOPUS:84982994525
SN - 1553-7366
VL - 12
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 7
M1 - e1005777
ER -